249 related articles for article (PubMed ID: 15309305)
1. [Botulinum toxin in urology. Indications and results].
Schurch B; Reitz A
Urologe A; 2004 Nov; 43(11):1410-5. PubMed ID: 15309305
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
Leippold T; Reitz A; Schurch B
Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
[TBL] [Abstract][Full Text] [Related]
4. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
De Laet K; Wyndaele JJ
Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin in urology. An inventory].
Schulte-Baukloh H; Knispel HH
Urologe A; 2004 Aug; 43(8):963-75. PubMed ID: 15278202
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders.
Lin YH; Chiang BJ; Liao CH
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085522
[TBL] [Abstract][Full Text] [Related]
7. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results.
Karsenty G; Baazeem A; Elzayat E; Corcos J
Can J Urol; 2006 Apr; 13(2):3027-33. PubMed ID: 16672114
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
Rajkumar GN; Conn IG
Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922
[No Abstract] [Full Text] [Related]
9. The role of botulinum toxin in neurourology.
Schurch B
Drugs Today (Barc); 2004 Mar; 40(3):205-12. PubMed ID: 15148529
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.
Herschorn S; Gajewski J; Ethans K; Corcos J; Carlson K; Bailly G; Bard R; Valiquette L; Baverstock R; Carr L; Radomski S
J Urol; 2011 Jun; 185(6):2229-35. PubMed ID: 21497851
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections].
Karsenty G; Corcos J; Schurch B; Ruffion A; Chartier-Kastler E
Prog Urol; 2007 May; 17(3):568-75. PubMed ID: 17622092
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection for lower urinary tract dysfunction.
Kuo YC; Kuo HC
Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
[TBL] [Abstract][Full Text] [Related]
13. Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study.
Krhut J; Samal V; Nemec D; Zvara P
Spinal Cord; 2012 Dec; 50(12):904-7. PubMed ID: 22801191
[TBL] [Abstract][Full Text] [Related]
14. Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature.
Moore DC; Cohn JA; Dmochowski RR
Toxins (Basel); 2016 Mar; 8(4):88. PubMed ID: 27023601
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity.
Veeratterapillay R; Harding C; Teo L; Vasdev N; Abroaf A; Dorkin TJ; Pickard RS; Hasan T; Thorpe AC
Int J Urol; 2014 Feb; 21(2):175-8. PubMed ID: 23819724
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin for overactive bladder].
Ziegelmüller BK; Sommer A; Bauer RM
Urologe A; 2020 Aug; 59(8):963-972. PubMed ID: 32691107
[TBL] [Abstract][Full Text] [Related]
17. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections.
Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M
J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment for bladder dysfunction.
Santos-Silva A; da Silva CM; Cruz F
Int J Urol; 2013 Oct; 20(10):956-62. PubMed ID: 23634720
[TBL] [Abstract][Full Text] [Related]
19. Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.
Gallien P; Reymann JM; Amarenco G; Nicolas B; de Sèze M; Bellissant E
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1670-6. PubMed ID: 16291892
[TBL] [Abstract][Full Text] [Related]
20. [What role does botulinum toxin play in the treatment of benign prostatic hyperplasia?].
Mazdar A; Bedouche A; Zoughari S; Ibrahimi A; Sayegh HE; Iken A; Benslimane L; Nouini Y
Pan Afr Med J; 2016; 24():309. PubMed ID: 28154664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
